372 related articles for article (PubMed ID: 12578487)
1. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.
Kay J; Chow WH; Chan TM; Lo SK; Kwok OH; Yip A; Fan K; Lee CH; Lam WF
JAMA; 2003 Feb; 289(5):553-8. PubMed ID: 12578487
[TBL] [Abstract][Full Text] [Related]
2. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure.
Shyu KG; Cheng JJ; Kuan P
J Am Coll Cardiol; 2002 Oct; 40(8):1383-8. PubMed ID: 12392825
[TBL] [Abstract][Full Text] [Related]
3. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432
[TBL] [Abstract][Full Text] [Related]
4. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.
Tepel M; van der Giet M; Schwarzfeld C; Laufer U; Liermann D; Zidek W
N Engl J Med; 2000 Jul; 343(3):180-4. PubMed ID: 10900277
[TBL] [Abstract][Full Text] [Related]
5. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
[TBL] [Abstract][Full Text] [Related]
6. The role of N-acetylcysteine in the prevention of contrast-induced nephrotoxicity.
Sandhu C; Belli AM; Oliveira DB
Cardiovasc Intervent Radiol; 2006; 29(3):344-7. PubMed ID: 16502177
[TBL] [Abstract][Full Text] [Related]
7. Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results.
Kimmel M; Butscheid M; Brenner S; Kuhlmann U; Klotz U; Alscher DM
Nephrol Dial Transplant; 2008 Apr; 23(4):1241-5. PubMed ID: 18174269
[TBL] [Abstract][Full Text] [Related]
8. Acetylcysteine, coronary procedure and prevention of contrast-induced worsening of renal function: which benefit for which patient?
Kefer JM; Hanet CE; Boitte S; Wilmotte L; De Kock M
Acta Cardiol; 2003 Dec; 58(6):555-60. PubMed ID: 14713182
[TBL] [Abstract][Full Text] [Related]
9. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
[TBL] [Abstract][Full Text] [Related]
10. Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial.
Fung JW; Szeto CC; Chan WW; Kum LC; Chan AK; Wong JT; Wu EB; Yip GW; Chan JY; Yu CM; Woo KS; Sanderson JE
Am J Kidney Dis; 2004 May; 43(5):801-8. PubMed ID: 15112170
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of N-acetylcysteine and hydration versus placebo and hydration in decreasing contrast-induced renal dysfunction in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention.
Seyon RA; Jensen LA; Ferguson IA; Williams RG
Heart Lung; 2007; 36(3):195-204. PubMed ID: 17509426
[TBL] [Abstract][Full Text] [Related]
12. Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions.
Ramesh N; Pillai RK; Abraham T; Padmaja NP; Hameed S; Vijayaraghavan G
J Assoc Physicians India; 2006 Jun; 54():449-52. PubMed ID: 16909692
[TBL] [Abstract][Full Text] [Related]
13. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial).
Diaz-Sandoval LJ; Kosowsky BD; Losordo DW
Am J Cardiol; 2002 Feb; 89(3):356-8. PubMed ID: 11809444
[No Abstract] [Full Text] [Related]
14. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.
Goldenberg I; Shechter M; Matetzky S; Jonas M; Adam M; Pres H; Elian D; Agranat O; Schwammenthal E; Guetta V
Eur Heart J; 2004 Feb; 25(3):212-8. PubMed ID: 14972421
[TBL] [Abstract][Full Text] [Related]
15. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial.
Burns KE; Chu MW; Novick RJ; Fox SA; Gallo K; Martin CM; Stitt LW; Heidenheim AP; Myers ML; Moist L
JAMA; 2005 Jul; 294(3):342-50. PubMed ID: 16030279
[TBL] [Abstract][Full Text] [Related]
16. Acetylcysteine and renal function following coronary angiographic procedures.
Bagshaw SM; Culleton BF
JAMA; 2003 Jun; 289(21):2795; author reply 2796. PubMed ID: 12783908
[No Abstract] [Full Text] [Related]
17. Acetylcysteine and renal function following coronary angiographic procedures.
Balderramo DC
JAMA; 2003 Jun; 289(21):2795-6; author reply 2796. PubMed ID: 12783907
[No Abstract] [Full Text] [Related]
18. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
[TBL] [Abstract][Full Text] [Related]
19. Acetylcysteine and contrast agent-associated nephrotoxicity.
Briguori C; Manganelli F; Scarpato P; Elia PP; Golia B; Riviezzo G; Lepore S; Librera M; Villari B; Colombo A; Ricciardelli B
J Am Coll Cardiol; 2002 Jul; 40(2):298-303. PubMed ID: 12106935
[TBL] [Abstract][Full Text] [Related]
20. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
